Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMB002 hepatocyte microbead transplantation for paediatric acute liver failure
ISRCTN14716227Phase 2Recruiting
- Sponsor
- King's College Hospital
- Start
- Jun 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, open-label, single-arm trial of HMB-002 in fulminant hepatitis, sponsored by King's College Hospital. Primary endpoints: Safety, Tolerability and 1 more. Started Jun 2025; status: recruiting.
02
Drugs
HMB-002
03
Conditions
fulminant hepatitis
Beyond the preview
Go deeper on ISRCTN14716227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14716227.